AXIM Biotechnologies, Inc.

AXIM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-K/A Apr 26, 2021 FORM 10-K/A AMENDED ANNUAL REPORT
10-K Apr 15, 2021 FORM 10-K ANNUAL REPORT
NT 10-K Mar 30, 2021 FORM 12B-25 NOTICE OF LATE FILING
10-Q/A Nov 27, 2020 FORM 10-Q/A AMENDED QUARTERLY REPORT
10-Q Nov 20, 2020 FORM 10-Q QUARTERLY REPORT
NT 10-Q Nov 16, 2020 FORM 12B-25 NOTICE OF LATE FILING
10-Q/A Aug 18, 2020 FORM 10-Q/A AMENDED QUARTERLY REPORT
10-Q Aug 14, 2020 FORM 10-Q QUARTERLY REPORT
8-K Jul 24, 2020 FORM 8K CURRENT REPORT
10-Q/A Jul 2, 2020 FORM 10-Q/A AMENDED QUARTERLY REPORT
10-Q Jun 29, 2020 FORM 10-Q QUARTERLY REPORT
NT 10-Q Jun 29, 2020 FORM 12B25 EXTENSION
D Jun 15, 2020
8-K/A May 29, 2020 FORM 8-K/A AMENDED CURRENT REPORT
10-K/A May 20, 2020 FORM 10-K/A ANNUAL REPORT
8-K May 14, 2020 FORM 8-K CURRENT REPORT
10-K May 14, 2020 FORM 10-K ANNUAL REPORT
8-K May 13, 2020 FORM 8K CURRENT REPORT
8-K May 12, 2020 FORM 8K CURRENT REPORT
8-K Mar 27, 2020 FORM 8K CURRENT REPORT
8-K Mar 19, 2020 FORM 8K CURRENT REPORT
UPLOAD Jan 10, 2020
8-K Jan 8, 2020 FORM 8K CURRENT REPORT
CORRESP Dec 23, 2019
8-K Dec 17, 2019 FORM 8K CURRENT REPORT
← Newer Page 5 of 13 · 306 filings Older →